Clinical trial
Long-acting HIV Pre-Exposure Prophylaxis Integrated With Community-based Sexual and Reproductive Health in South Africa (LAPIS): A Hybrid (1a) Cluster Randomised Controlled Phase 3B Trial of Effectiveness and Implementation
NCT06250504 is registered in ClinicalTrials.gov with Africa Health Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-acting HIV Pre-Exposure Prophylaxis Integrated With Community-based Sexual and Reproductive Health in South Africa (LAPIS): A Hybrid (1a) Cluster Randomised Controlled Phase 3B Trial of Effectiveness and Implementation
- Lead sponsor
- Africa Health Research Institute
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- February 27, 2024
- Completion date
- October 31, 2026
- Enrollment
- 2,052 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.